• Home
  • Stocks
  • Welcure Drugs & Pharmaceuticals Ltd.

Welcure Drugs & Pharmaceuticals Ltd.

View in App
3.98 +0.04 ▲1.0%

01 June 2023, 02:35:00 PM
Volume: 13,222

Company Profile

View details >>
Sector Trading Compare with Sector peers
Industry Trading Compare with Industry peers
Website http://www.welcuredrugs.com
Market Cap 5.43 Cr.
Enterprise Value(EV) 5.32 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 0.00 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-12
Industry PE 49.08 Trailing Twelve Months Ending 2022-12
Book Value / Share 1.05 Trailing Twelve Months Ending 2022-12
Price to Book Value 3.82 Calculated using Price: 4.02
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.35 Cr. 13,512,100 Shares
FaceValue 10
About Welcure Drugs & Pharmaceuticals Ltd.
Welcure Drugs & Pharmaceuticals Ltd. (WDPL) was incorporated as a Public Limited Company under the Companies Act, 1956 on 4th June, 1992 and obtained the certificate of commencement of business on 19th June 1992.

Welcure Drugs & Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Welcure Drugs & Pharmaceuticals Ltd. Performance

View details >>
1 Day
+1.02%
1 Week
+1.02%
1 Month
-2.45%
3 Month
-8.08%
6 Month
-13.29%
1 Year
-42.73%
2 Year
+59.20%
5 Year
+279.05%
10 Year
+142.68%

Welcure Drugs & Pharmaceuticals Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 108.61 -65.80 17.83 -49.46 131.74 29.03
Return on Capital Employed (%) 108.91 -65.46 18.22 -48.94 131.94 29.12
Return on Assets (%) 5.68 10.40 227.41 94.50 -58.62 14.57 -34.54 112.99 27.77

Welcure Drugs & Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 0 0 0 0 0 0 0 0 0 1
Non Curr. Liab.
Curr. Liab. 0 0 0 0 0
Minority Int.
Equity & Liab. 0 0 0 0 0 0 0 0 0 1
Non Curr. Assets 0
Curr. Assets 0 0 0 0 0 0 0 0 0 1
Misc. Exp. not W/O
Total Assets 0 0 0 0 0 0 0 0 0 1

Welcure Drugs & Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 0 0 0 0 0 0 0 0 0 0
Other Income 0 0 0
Total Income 0 0 0 0 0 0 0 0 0 0
Total Expenditure 0 0 0 0 0 0 0 0 0 0
PBIDT 0 0 0 0 0 0 0
Interest
Depreciation
Taxation
Exceptional Items
PAT 0 0 0 0 0 0 0
Adjusted EPS 0 0 0 0 0 0

Welcure Drugs & Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 0 0 0
Cash Fr. Inv. 0 0 0
Cash Fr. Finan.
Net Change 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Welcure Drugs & Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 14.12 14.12 14.12 14.12 14.12 14.12 0.00 0.00 0.00
Public 85.88 85.88 85.88 85.88 85.88 85.88 100.00 100.00 100.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Welcure Drugs & Pharmaceuticals Ltd. Announcements

View details >>
Mon, 29 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
In pursuant to SEBI Circular No CIR/CFD/CMD 1/27/2019 dated February 08 2019 and Regulation 24A of SEBI (Listing Obligation and Disclosure Requirement) Regulation 2015 we are attaching herewith the Annual Secretarial Compliance Report of Welcure Drugs & Pharmaceuticals Ltd issued by M/s V Kumar & Associates Practicing Company Secretaries dated May 29th 2023 for the financial year ended 31st March 2023.
Tue, 23 May 2023
Board Meeting Intimation for Prior Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 And Information Regarding Reopening Of Trading Window Of Equity Shares Of The Company
WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve With reference to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of Board of Directors of Welcure Drugs & Pharmaceuticals Limited will be held on Monday 29th May 2023 at 3:00 P.M. at the registered office of the company inter alia to transact the following matters:1. To consider and take on record the Audited Financial Results for Quarter & Year ended 31st March 2023.2. Any other business as may be considered necessary.We further wish to inform you that as per requirement the Trading Window of Equity Shares of the Company shall reopen on 1st June 2023.
Sat, 13 May 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
In compliance with Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 and based on the intimation received from the Companys Registrar and Share Transfer Agents M/s. Link lntime India Private Limited we would like to inform regarding issue of duplicate shares certificates in lieu of lost share certificate(s) for the following shareholder (s):Date of receipt of intimation Folio No Name Certificate No. Distinctive No. No. of Shares Reason 12th May 2023 0041193 Chandeshwar Prasad Yadav 119661 13491901-13492000 100 Lost by Holder 119661 13493201- 13493300 100 119661 13493401- 13493500 100 119661 13493501- 13493600 100 119661 13493601- 13493700 100 The duplicate share certificate(s) will be issued to the shareholder(s) shortly

Welcure Drugs & Pharmaceuticals Ltd. Technical Scans

View details >>
Wed, 31 May 2023
Opening at High Opening at High
High Decrease in 1 Year High Decrease in 1 Year
High Increase in 2 Years High Increase in 2 Years
High Increase in 5 Years High Increase in 5 Years
Closing Near 20 SMA Closing Near 20 SMA

Welcure Drugs & Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. 284,344.78 2,499.25 +0.2%
Redington Ltd. 13,631.15 182.10 +4.6%
MMTC Ltd. 4,500.00 30.05 +0.3%
Landmark Cars Ltd. 2,786.81 693.35 -1.4%
Optiemus Infracom Ltd. 1,994.46 234.50 +0.9%
SIRCA Paints India Ltd. 1,647.28 304.80 +1.2%
Polo Queen Industrial & Fintech Ltd. 1,414.18 42.00 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 114.98 2,499.25 +0.2%
Redington Ltd. Consolidated 2023-03 9.85 182.10 +4.6%
MMTC Ltd. Consolidated 2023-03 2.88 30.05 +0.3%
Landmark Cars Ltd. Consolidated 2023-03 33.24 693.35 -1.4%
Optiemus Infracom Ltd. Consolidated 2023-03 47.72 234.50 +0.9%
SIRCA Paints India Ltd. Consolidated 2023-03 35.99 304.80 +1.2%
Polo Queen Industrial & Fintech Ltd. Consolidated 2023-03 604.55 42.00 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2023-03 8.60 2,499.25 +0.2%
Redington Ltd. Consolidated 2023-03 1.98 182.10 +4.6%
MMTC Ltd. Consolidated 2023-03 3.27 30.05 +0.3%
Landmark Cars Ltd. Consolidated 2023-03 3.45 693.35 -1.4%
Optiemus Infracom Ltd. Consolidated 2023-03 5.22 234.50 +0.9%
SIRCA Paints India Ltd. Consolidated 2023-03 5.67 304.80 +1.2%
Polo Queen Industrial & Fintech Ltd. Consolidated 2023-03 8.74 42.00 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 1.82 2,499.25 +0.2%
Redington Ltd. Consolidated 2022-03 0.11 182.10 +4.6%
MMTC Ltd. Consolidated 2022-03 -17.70 30.05 +0.3%
Landmark Cars Ltd. Consolidated 2022-03 1.02 693.35 -1.4%
Optiemus Infracom Ltd. Consolidated 2022-03 0.13 234.50 +0.9%
SIRCA Paints India Ltd. Consolidated 2022-03 0.00 304.80 +1.2%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-03 0.10 42.00 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 2.41 2,499.25 +0.2%
Redington Ltd. Consolidated 2022-03 24.61 182.10 +4.6%
MMTC Ltd. Consolidated 2022-03 0.00 30.05 +0.3%
Landmark Cars Ltd. Consolidated 2022-03 31.70 693.35 -1.4%
Optiemus Infracom Ltd. Consolidated 2022-03 -0.28 234.50 +0.9%
SIRCA Paints India Ltd. Consolidated 2022-03 12.99 304.80 +1.2%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-03 0.89 42.00 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 2.41 2,499.25 +0.2%
Redington Ltd. Consolidated 2022-03 24.61 182.10 +4.6%
MMTC Ltd. Consolidated 2022-03 0.00 30.05 +0.3%
Landmark Cars Ltd. Consolidated 2022-03 31.70 693.35 -1.4%
Optiemus Infracom Ltd. Consolidated 2022-03 -0.28 234.50 +0.9%
SIRCA Paints India Ltd. Consolidated 2022-03 12.99 304.80 +1.2%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-03 0.89 42.00 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 69,420.18 2,499.25 +0.2%
Redington Ltd. Consolidated 2022-03 62,644.01 182.10 +4.6%
MMTC Ltd. Consolidated 2022-03 11,796.24 30.05 +0.3%
Landmark Cars Ltd. Consolidated 2022-03 2,976.52 693.35 -1.4%
Optiemus Infracom Ltd. Consolidated 2022-03 471.63 234.50 +0.9%
SIRCA Paints India Ltd. Consolidated 2022-03 200.02 304.80 +1.2%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-03 56.55 42.00 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2022-03 475.37 2,499.25 +0.2%
Redington Ltd. Consolidated 2022-03 1,314.87 182.10 +4.6%
MMTC Ltd. Consolidated 2022-03 -262.38 30.05 +0.3%
Landmark Cars Ltd. Consolidated 2022-03 66.18 693.35 -1.4%
Optiemus Infracom Ltd. Consolidated 2022-03 -0.92 234.50 +0.9%
SIRCA Paints India Ltd. Consolidated 2022-03 27.72 304.80 +1.2%
Polo Queen Industrial & Fintech Ltd. Consolidated 2022-03 1.43 42.00 -0.3%

Welcure Drugs & Pharmaceuticals Ltd. FAQ's

What is Welcure Drugs&Pharma share price?
Can I buy Welcure Drugs&Pharma shares now?
What is the Market Cap of Welcure Drugs&Pharma?
What are the key metrics to analyse Welcure Drugs&Pharma?
What is the 52 Week High and Low of Welcure Drugs&Pharma?
What is the trend of Welcure Drugs&Pharma share price?